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Abstract
Background: The preventive role of acute occurring of collateral circulation (AOCC) to infarct related 
artery (IRA) in patients presenting with acute ST-segment elevation myocardial infarction (STEMI) 
is well known. Therefore, we aimed to investigate whether there is an association between admission 
plasma 25-hydroxyvitamin D (25(OH)D3) levels and grade of collateralization in patients with STEMI.
Methods: We prospectively included 369 STEMI patients within the first 12 h of symptoms onset. 
Patients were divided into two groups according to their Rentrop collateralization grade to IRA: poorly 
developed collateral (PDC) group (Rentrop grade ≤ 1, 272 patients) and well developed collateral (WDC) 
group (Rentrop grade ≥ 2, 97 patients).
Results: We observed that AOCC grade to IRA was negatively correlated with high sensitive C-reactive 
protein (hs-CRP), N terminal pro-B-type natriuretic peptide (NT-proBNP), as well as peak troponin 
T levels, yet positively correlated with admission plasma 25(OH)D3 level (p < 0.05, for all). In multi-
variate analysis, 25(OH)D3 levels (OR 1.246, 95% CI 1.185–1.310, p < 0.001), together with hs-CRP, 
NT-proBNP, and peak troponin T levels were found independent predictors of AOCC to IRA in patients 
with acute STEMI.
Conclusions: Admission level of plasma 25(OH)D3 levels together with cardiac risk biomarkers 
(troponin T, NT-proBNP, hs-CRP) are associated with collateralization grade to IRA in acute STEMI 
patients. In addition, 25(OH)D3 may be a promoter of AOCC in patients with acute STEMI. (Cardiol J  
2017; 24, 6: 677–684)
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Introduction
Coronary collaterals are anastomotic conduits 
that can provide an alternative source of blood 
supply to jeopardized myocardium by acutely or 
chronically developed occlusive coronary artery 
disease [1, 2]. Acute occurring of coronary col-
lateral circulation (AOCC) to infarct related artery 
(IRA) territory after onset of acute ST-segment 
elevation myocardial infarction (STEMI) has shown 
various beneficial effects on infarct size, ventricular 
function, microvascular circulation, hemodynamic 
status, and mortality [3–5]. In addition, existence 
of a chronic total occlusion (CTO) is another im-
portant process which leads to coronary collateral 
development. These chronically occurring collater-
als to CTO also have various protective effects on 
myocardial viability, remodeling, and cardiovascular 
outcomes [6, 7].
Vitamin D is a steroidal hormone and plays 
a crucial role in various metabolic pathways, par-
ticularly in cardiovascular system. Epidemiological 
studies have shown an independent relationship 
between low vitamin D levels and cardiovascu-
lar risk factors (hypertension, diabetes mellitus, 
metabolic syndrome), cardiac events (myocardial 
infarction, congestive heart failure), and mortality 
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there is a positive correlation between serum 
vitamin D levels and the development of collat-
eral vessels to a totally occluded artery [12, 21]. 
Furthermore, the effect of serum vitamin D levels 
on collateralization grade of CTO artery has been 
established, and a positive correlation was ob-
served [12, 13]. To the best of our knowledge, the 
effect of plasma 25-hydroxyvitamin D (25(OH)D3) 
levels on acute collateralization grade to IRA has 
not yet been studied. Accordingly, we aimed to in-
vestigate whether there is a relationship between 
admission plasma 25(OH)D3 levels and AOCC to 
the IRA in patients with acute STEMI.
Methods
Study population
In this prospective study, we enrolled 369 
acute STEMI patients who underwent primary 
percutaneous coronary intervention (PCI) between 
May 2015 and November 2015. We included pa-
tients with symptoms of ischemic chest pain (at 
least for 30 min, and no longer than 12 h), and an 
electrocardiography (ECG) showing ST-segment 
elevation of 0.1 mV in two or more limb leads, 
or 0.2 mV in two or more contiguous precordial 
leads, or presumed new left bundle branch block. 
Angiographic evaluation of IRA and non-IRA was 
performed before primary PCI by two experienced 
cardiologists who were blinded to the study data. 
Rentrop collateral classification was used for grad-
ing AOCC to IRA territory on angiography. Rentrop 
classification was defined as follows: grade 0: no 
visible filling of any collateral channel; grade 1: fill-
ing of the side branches of the occluded artery, with 
no dye reaching the epicardial segment; grade 2: 
partial filling of the epicardial vessel; and grade 3: 
complete filling of epicardial vessel by collateral 
vessels [14]. In addition, both post-PCI thromboly-
sis in myocardial infarction (TIMI) flow grade in 
IRA and post-PCI TIMI myocardial perfusion grade 
(MPG) were assessed. After grading collateraliza-
tion, patients who had Rentrop ≤ 1 were defined as 
those with poorly developed collateral (PDC) group 
and patients who had Rentrop ≥ 2 defined as well 
developed collateral (WDC) group.
Pre-infarct angina was defined as at least 
one episode of typical transient (< 30 min) chest 
pain (Canadian Cardiovascular Society ≥ 1), in the 
preceding 24 h of index event. All patients were 
carefully assessed for pre-infarct angina. Coronary 
artery disease extension was calculated with Sul-
livan score, as described previously [15].
The general health status and functional ca-
pacity of the participants were assessed after the 
primary PCI. The patients on vitamin D or calcium 
supplementation, or with hyperparathyroidism or 
hypercalcemia, the patients with prior bone fracture 
or any musculoskeletal system disorder, previous 
coronary interventional procedures (by-pass graft 
surgery or PCI), oncological and hematological 
disorders, severe renal or hepatic failure, asthma, 
chronic and active inflammatory diseases, patients 
who showed TIMI flow grade > 1 at first contrast 
injection in the IRA, and patients admitted later than 
12 h after chest pain onset were excluded from the 
study. Of 428 patients with acute STEMI enrolled 
in our study, 59 patients were excluded from the 
present analysis due to the following reasons: 
21 patients with TIMI > 1 flow in the IRA at 
the first contrast injection, 12 patients admit-
ted later than 12 h after chest pain onset, 5 pa-
tients with inadequate quality of angiographic 
image, 6 patients with coronary artery bypass 
grafting, 4 patients with severe renal failure, 
3 patients with prior bone fracture, and 8 patients 
who were on vitamin D or calcium supplementation.
The institutional Ethics Committee approved 
the study, and each participant provided their writ-
ten informed consent.
Laboratory analysis
Laboratory analyses include routine complete 
blood count, biochemistry, para-thyroid hormone, 
N-terminal pro-B-type natriuretic peptide (NT-
-proBNP) and high sensitive C-reactive protein 
(hs-CRP) levels. Study procedure allowed us to 
measure the 25(OH)D3 levels before primary PCI 
application. Centrifuge used to separate serum and 
plasma, and materials were stored at –80°C until the 
test time. Serum 25(OH)D3 levels were measured 
by using a direct competitive chemiluminescent im-
munoassay (Elecsys; Roche Diagnostics, Maanheim, 
Germany). The detection threshold for 25(OH)D3 
was 3 ng/mL. The intra-assay and inter-assay coef-
ficient of variation were 4% and 7%, respectively.
The study was performed in Adana, Turkey, 
whose location is of a Mediterranean climate, with 
hot humid summers and soft climate in winters. 
Rainfall occurs during spring and autumn. The 
average temperatures of 40°C in summer and 8°C 
in winter were recorded.
Statistical analysis
Baseline, clinical and laboratory features of 
study patients were summarized as percentages 
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and frequencies for categorical variables and me-
dian values corresponding with 25th and 75th percen-
tiles (Q25 and Q75) for continuous variables. The 
Kolmogorov-Smirnov test was used to identify the 
correctness of the distribution of continuous vari-
ables. Categorical variables were compared using 
the c2 test. Pearson and Spearman correlation coef-
ficient was performed to examine the association 
between variables and AOCC. The effects of vari-
ous variables on collateralization were calculated 
by using a univariate analysis. Variables showing an 
unadjusted p < 0.10 in logistic regression analysis 
were determined as risk markers. All significant 
parameters in the univariate analysis were selected 
in the multivariate model. Multivariate, stepwise 
backward conditional logistic regression analysis 
was used to obtain the independent predictors of 
collateralization. A receiver-operating characteris-
tic (ROC) curve analysis was performed to identify 
the optimal cutoff point of 25(OH)D3 to predict the 
presence of AOCC to IRA. Statistical analysis was 
performed by using SPSS 17.0 for Windows (SPSS 
Inc., Chicago, Illinois, USA). A two-tailed p < 0.05 
was considered to be statistically significant.
Results
We included a total of 369 (75.1% male) acute 
STEMI patients with an average age of 57.7 ± 11.6 
years. Poor developed (Rentrop grade 0 or 1) and 
well developed (Rentrop grade 2 or 3) collateraliza-
tion was observed in 272 (73.7%) and 97 (26.3%) 
patients, respectively. The mean serum 25(OH)D3 
level of study population was 16.9 ± 8.8 ng/mL, 
and 68.3% of patients had 25(OH)D3 levels below 
20 ng/mL.
The WDC group was more likely to have bet-
ter baseline characteristic risk including younger 
age (56 [49;64] vs. 58.5 [50;67]; p = 0.034), and 
freedom from prior diabetes (22.7% vs. 36.4%; 
p = 0.016), however hypertension (58.8% vs. 
45.6%; p = 0.033) was higher when compared to 
the PDC group. The WDC group was also more 
likely to have presented with lower incidence of 
Killip class (at least two at admission), had higher 
left ventricular ejection fraction (LVEF), and lower 
in-hospital mortality rate (1% vs. 5.5%; p = 0.047). 
Other baseline and clinical features were similar 
between groups, which  has been shown in Table 1.
Among the laboratory findings, 25(OH)D3 
levels were significantly higher in WDC group as 
compared to PDC group (12 [10;18] ng/mL vs. 26 
[21;32] ng/mL; p < 0.001). A box plot graphic of 
plasma 25(OH)D3 levels for comparison of poorly 
and well developed collateral groups was shown in 
Figure 1. A significant positive correlation was also 
found between plasma 25(OH)D3 levels and AOCC 
to IRA (r = 0.577, p < 0.001). However, hs-CRP 
(r = –262, p < 0.001), NT-proBNP (r = –279, p < 
< 0.001) and peak troponin T (r = –105, p = 0.043) 
levels demonstrated negative correlations with 
AOCC to IRA (Table 2).
At univariate analysis, age, diabetes mellitus, 
hypertension, LVEF, pre-infarction angina, Killip 
class, hs-CRP, NT-proBNP, peak troponin T, and 
25(OH)D3 levels were obtained as determinants 
of AOCC to IRA. In multivariate analysis, 25(OH)
D3 levels (odds ratio [OR] 1.246, 95% confidence 
interval [CI] 1.185–1.310, p < 0.001) together 
with hs-CRP (OR 0.840, 95% CI 0.746–0.945, 
p = 0.004), NT-proBNP (OR 0.998, 95% CI 0.998–
–0.999, p = 0.001), and peak troponin T (OR 1.000, 
95% CI 1.000–1.000, p = 0.004) levels were found 
independent predictors of AOCC to IRA in patients 
with acute STEMI (Table 3). The cutoff value of 
admission plasma 25(OH)D3 level obtained by the 
ROC curve analysis was 10.5 ng/mL for prediction 
of AOCC to IRA (sensitivity: 96%, specificity: 
67%). The area under the ROC curve (AUC) was 
0.877 (95% CI 0.836–0.919, p < 0.001) (Fig. 2).
Discussion
The results of the present study have shown 
that in early hours of STEMI, collateralization 
grade to the IRA was independently associated 
with peak troponin T, NT-proBNP, hs-CRP, and 
admission plasma 25(OH)D3 levels.
The coronary collateral circulation is an im-
portant heart adaptation mechanism to prevent the 
ischemic myocardial injury, especially in the early 
hours of STEMI. After onset of acute STEMI, the 
incidence of AOCCs to IRA varies from 10% to 
40% [3, 16]. In the present study, AOCC to IRA 
were found in 26.3% of patients within the first 12 h 
of acute STEMI onset. It has also been reported 
that patients with angiographically determined high 
grade collateralization to IRA had lower frequency 
of cardiogenic shock, better microvascular reper-
fusion, and smaller infarct size when compared 
to the other group [3–5]. Similarly, according to 
our results, these protective effects of AOCC on 
microvascular reperfusion, such as better post-
PCI TIMI flow and post-PCI MBG, were more 
common in patients in WDC than PDC group. It is 
possible that AOCC to IRA due to high vitamin D 
level may lead to decreased microvascular injury 
and accelerated healing. We also observed higher 
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Table 1. Baseline and clinical characteristics of the study groups.
PDC group (n = 272) WDC group (n = 97) P*
Age [years] 58.5 [50;67] 56 [49;64] 0.034
Gender, male 201 (73.9%) 76 (78.4%) 0.415
Body mass index [kg/m2] 27.5 [24.6;29.4] 26.8 [24.1;29] 0.244
Hypertension 124 (45.6%) 57 (58.8%) 0.033
Diabetes mellitus 99 (36.4%) 22 (22.7%) 0.016
Smoking 156 (57.4%) 52 (53.6%) 0.552
Hyperlipidemia 46 (16.9%) 20 (20.6%) 0.441
Pre-infarction angina 53 (19.5%) 29 (30.2%) 0.033
Chest pain duration [h] 3.5 [2;5] 3 [2;5] 0.634
Previous myocardial infarction 45 (16.5%) 18 (18.8%) 0.638
Killip class ≥ 2 40 (14.7%) 6 (6.2%) 0.031
Left ventricular ejection fraction [%] 47 [38.6;52] 48 [42.1;52] 0.003
Culprit artery, LAD 139 (51.1%) 56 (57.7%) 0.287
Post-PCI TIMI ≥ 2 236 (86.7%) 92 (94.8%) 0.037
Post-PCI MBG > 2 55 (20.2%) 32 (33%) 0.017






In-hospital mortality 15 (5.5%) 1 (1%) 0.047
*t-test for independent samples and Pearson c2 test; data n (%) for categorical variables, median [interquartile range] for continuous variables; 
significant p values (p < 0.05) were indicated in boldface. LAD — left anterior descending artery; MBG — myocardial blush grade; PDC — 
poorly developed collateral; PCI — percuteneous coronary intervention; TIMI — thrombolysis in myocardial infarction; WDC — well  
developed collateral
Figure 1. Box plot graphic of plasma 25-hydroxyvitamin 
D levels in patients with poorly developed collateral 
(PDC) group and well developed collateral (WDC) group 
(12 [10;18] ng/mL vs. 26 [21;32] ng/mL; p < 0.001).
Figure 2. The receiver operating characteristic curve for 
25-hydroxyvitamin D level for predicting development 
of acute occurring of collaterals to infarct related artery; 
CI — confidence interval.
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values of NT-proBNP, and troponin T levels to-
gether with higher incidence of Killip level ≥ 2, 
and mortality rate in PDC group when compared 
with WDC group.
It should be emphasized that we observed 
median level for 25(OH)D3 being 26 [21;32] ng/mL 
in WDC group, which was suboptimal and very 
close to optimal level (30–50 ng/mL) [17]. On the 
other hand, PDC group was definitely vitamin 
D-deficient with median 12 [10;18] ng/mL. Therefore, 
we may speculate that vitamin D has an important 
role in collateral development in the acute setting 
of STEMI. Angiogenesis and arteriogenesis are 
two mechanisms for developing collateral circula-
tion as a response to myocardial ischemia [18]. 
Angiogenesis is a highly coordinated process and 
means formation of new capillary blood vessel 
from pre-existing blood vessel which requires 
interaction between endothelium, extracellular 
matrix, and surrounding cells mediated by growth 
Table 2. Laboratory findings of the study groups.
Variables PDC group (n = 272) WDC group (n = 97) P*
WBC count [×1000/µL] 11.4 [9.4;14] 12.6 [10;15.1] 0.149
Hemoglobin [mg/dL] 13.6 [11.8;14.4] 14 [12;15.1] 0.159
Creatinine [mg/dL] 0.8 [0.7; 1.0] 0.8 [0.7; 0.9] 0.595
Total cholesterol [mg/dL] 187 [165;214] 188 [163;208] 0.696
Triglyceride [mg/dL] 92 [64;174] 102 [76;155] 0.541
HDL-C [mg/dL] 39 [33;45] 38 [32;45] 0.336
LDL-C [mg/dL] 132 [111;154] 129 [109;148] 0.695
hs-CRP [mg/L] 5.2 [3.2;7.2] 3.2 [2.4;5.2] < 0.001
Peak troponin T [ng/mL] 1571 [574;3676] 1420 [666;2116] 0.004
NT-proBNP [pg/mL] 548 [161;1024] 234 [71;648] < 0.001
Calcium [mg/dL] 9.1 [8.8;9.6] 9.3 [8.6;9.7] 0.853
Parathyroid hormone 52.4 [35;78] 53.9 [36.1;78] 0.626
25-hydroxyvitamin D [ng/mL] 12 [10;18] 26 [21;32] < 0.001
*t-test for independent samples, data are median [interquartile range]; significant p values (p < 0.05) were indicated in boldface. HDL-C — 
high-density lipoprotein cholesterol; hs-CRP — high sensitive C reactive protein; LDL-C — low-density lipoprotein cholesterol; NT-proBNP — 
N terminal pro-B-type natriuretic peptide; PDC — well developed collateral; WBC — white blood cell; WDC — well developed collateral
Table 3. Significant predictors of acute occurring of collaterals to infarct related artery in univariable 
and multivariable logistic regression analyses.
Univariate Multivariate
OR 95% CI P OR 95% CI P
Age 0.979 0.959–0.998 0.035
Hypertension 0.588 0.368–0.940 0.027
Diabetes mellitus 0.513 0.300–0.876 0.014
Killip class ≥ 2 0.382 0.157–0.933 0.035
Pre-infarction angina 1.789 1.054–3.035 0.031
Ejection fraction 1.042 1.013–1.072 0.004
Sullivan score 0.984 0.965–1.002 0.080
Hs-CRP 0.813 0.738–0.894 < 0.001 0.840 0.746–0.945 < 0.004
Peak troponin T 1.000 1.000–1000 0.011 1.000 1.000–1000 0.004
NT-proBNP 0.998 0.998–0.999 < 0.001 0.998 0.998–0.999 0.001
25-hydroxyvitamin D 1.236 1.182–1.293 < 0.001 1.246 1.185–1.310 < 0.001
Significant p values (p < 0.05) were indicated in boldface. CI — confidence interval; Hs-CRP — high sensitive C-reactive protein; NT-proBNP —  
N terminal pro-B-type natriuretic peptide; OR — odds ratio
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factors such as vascular endothelial growth factor 
(VEGF) [19]. The VEGF is one of these growth 
factors and improves impaired endothelium de-
pendent relaxation of collaterals by nitric oxide 
(NO) mediated mechanism which is an important 
regulator of collateral growth [20, 21]. The VEGF 
mRNA and its ligand expression can occur within 
minutes due to myocardial ischemia [19, 22]. In 
a previous report, Ni et al. [23] demonstrated that 
blocking vitamin D receptors in mice caused a re-
duction in endothelial NO synthesis expression and 
endothelial function. Although it has been shown 
that vitamin D plays a key role in NO modulation 
in endothelial regeneration by stimulating VEGF 
and increasing the circulating endothelial progeni-
tor cells (EPCs) [24, 25].
The stromal cell-derived factor 1 (SDF-1) 
and its ligand CXCR4 is another axis to promote 
angiogenesis. The homing of EPCs to the site of 
vascular injury depends on CXCR4 receptors [25, 
26]. The injured vascular site and 25(OH)D3 stimu-
lation have to be required together for synthesis 
and release SDF-1 from the injured tissue cells, 
which then mediate chemotatic stimulus to EPCs. 
25(OH)D3 also increases the level of SDF-1 at the 
site of injured tissue by stimulating EPCs [25, 26].
Arteriogenesis is an alternative mechanism for 
collateral remodeling, mediated by change in shear 
stress. The pressure gradient between intercon-
necting network increases the blood flow velocity 
and fluid shear stress leads to collateral develop-
ment due to occlusion of coronary artery [27, 28]. 
Stimulus of increased shear stress is transmitted 
to endothelial nucleus and leads to expression of 
several genes, including NO synthase, VEGF, and 
monocyte chemoattractant protein 1 (MCP-1). 
MCP-1 is a potent arteriogenic peptide [29]. In 
addition to chemoattractive effect on monocyte, 
VEGF receptor pathways have crosstalk with 
SDF-1 receptor pathways. Thus, shear stress 
may contribute to increase in the collateral flow 
by SDF-1 mediated mechanism [30]. Taken to-
gether, angiogenesis and arteriogenesis are two 
mechanisms of vessel growth, and vitamin D may 
contribute in various pathways of these processes 
to collateral remodeling.
The progression of atherosclerotic process 
and its acute complications are strongly related 
with low grade inflammation. Hs-CRP, one of the 
biomarkers of this inflammation, predicts cardio-
vascular risk [31]. Endothelial dysfunction seems 
to be a possible mechanism for explaining the 
role of hs-CRP in AOCCs to IRA. Previously it 
had been shown that increased levels of hs-CRP 
resulted in decreased expression of NO synthase, 
prostacyclin, up-regulation of endothelial adhesion 
molecules, and increased levels of superoxide 
radicals in vascular bed [32, 33]. Early after onset 
of ischemia, NO synthase activity increases and 
plays an important role in arteriogenesis by NO 
dependent vasodilatation of coronary collaterals 
[34]. Likewise, in our study, that inverse relation-
ship between NO and hs-CRP contributes to the 
mechanism of inadequate AOCC to IRA.
Finally, we found that diabetes mellitus was 
associated with poor collateral development to-
wards IRA in the acute setting of STEMI. Previous 
clinical and experimental studies have reported 
conflicting results about collateral development 
in diabetic or non-diabetic patients in the acute 
setting of myocardial infarction [35, 36]. It is well 
known that endothelial dysfunction and decreased 
NO synthesis are main features of diabetes mel-
litus. In addition, Mieno et al. [37] reported that 
diabetic patients have decreased EPC proliferation 
due to impaired VEGF stimulation. Accordingly, 
diabetic patients are more likely to have poor col-
lateral development because of these underlying 
mechanisms in collateral development. However, 
several studies demonstrated better coronary col-
laterals in diabetic groups than in non-diabetics 
[35, 38]. The genetic factors could be a possible 
explanation and may interact with diabetes to 
improve the collateralization grade to IRA. Lin et 
al. [35] demonstrated that VEGF polymorphism 
in diabetic patients with the VEGF +405 C>G 
polymorphism had better collaterals than those 
without it. Another possible explanation could be 
that the experience of the first cardiac event of 
diabetic patients may occur at an advanced stage 
of atherosclerosis which is a critical predictor of 
collateral presence, as demonstrated by Niccoli et 
al. [38]. Even though, we found similar coronary 
extension score calculated by Sullivan scoring sys-
tem [15] between the two groups. In this regard, 
we may conclude that this is the reason why the 
presence of previous acute myocardial infarction 
or advanced coronary atherosclerosis was not dif-
ferent between the two groups.
Limitations of the study
Our study has some limitations to be men-
tioned. Firstly, the diameter of collateral vessels 
under 100 µm could not be observed due to angio-
graphic limitations. We also did not use indirect 
methods to better quantify the collateral flow, 
such as myocardial contrast-echocardiography of 
pressure-derived collateral flow index. In addition, 
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the results provided here cannot be generalized 
to all patients due to the fact that this is a single 
center study and our population included only one 
geographical region. Due to the nature of cross-
sectional studies, our study could not support 
a causal relationship and requires confirmation in 
further well designed clinical trials. It is also impor-
tant to remember that vitamin D status can change 
with various factors, such as season, geography, 
latitude, and sunlight exposure.
Conclusions
In conclusion, coronary collateral circulation 
is a complex process stimulated and mediated by 
various endogenous mediators including VEGF, 
SDF-1, MCP-1, NO, inflammatory markers, and 
neurohumoral markers. In addition to cardiac risk 
biomarkers, such as troponin T, NT-proBNP, or 
hs-CRP, our study also found that admission plasma 
25(OH)D3 levels were associated with AOCC to 
IRA in acute STEMI patients. Therefore, vitamin 
D may be an important required hormone in inter-
action of various vascular regenerative pathways 
for collateral development in patients with acute 
STEMI. Its close relationship with AOCC may be 
a reasonable cause of poor prognosis in STEMI 
patients with vitamin D deficiency.
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